It would be fair to say biotech has had an interesting time of it over the course of the past 15 months. Except, of course, that biotech always has an interesting time of it. The go big or go home sector of the market attracts speculators, scientists, and unsavory characters, but also attracts people hoping for critical improvements to their healthcare options.
Who knows what is going on with health care legislation? I am still interested in how any potential changes could affect older workers.
The need for medical care rises sharply after age 50. Obamacare the Affordable Care Act of 2010 increased the coverage of these older adults by expanding Medicaid, restructuring the insurance market, and offering subsides. The repeal and replace legislation....More>>>
Downbeat holiday sales reports byKohl’s(NYSE:KSS) andMacy’s(NYSE:M) pushed the department store sector, and much of retail, in the red on Thursday. As of 11:38 a.m. EST, Kohl’s was down 19.5%, Macy’s was down 14.4%, and peers includingNordstrom(NYSE: JWN) andJ.C. Penney(NYSE: JCP) also tumbled, falling 9.8% and....More>>>
The Paradise Papers leak this past Sunday wasn't shocking.
If anything, the varied revelations about what celebrities and corporations use offshore tax shelters only further justify the general public's long-standing suspicion that the rich and powerful cheat on their taxes.<
DIS,NFLX,SNAP,Walt Disney Co (NYSE:DIS) stocksaw an uptick in spite of disappointing Q4 earnings results. Can DIS stock keep rising from here?,
Media and entertainment conglomerate Walt Disney Co (NYSE:DIS) reported its fiscal fourth-quarter earnings on Thursday, after the market close which was disappointing on almost all fronts. The House of Mouse missed both the top and bottom line numbers and had initially slipped in the
Alphabet (GOOGL) doesn't seem like your typical growth stock, considering it opened at $1,030.99 this morning (Oct. 27, 2017). But Wall Street is overlooking the explosive potential our tech guru sees…
Money Morning Director of Technology & Venture Capital Research